TOKSOPLASMOSIS OKULAR KONGENITAL
Abstract
Abstrak. Infeksi toksoplasmosis pada ibu dalam masa kehamilan dapat menyebabkan infeksi kongenital terhadap janin yang akan mengakibatkan kebutaan pada waktu bayi. Diperkirakan 0,5%-1% wanita hamil di dunia berpotensi terinfeksi kuman Toksoplasma gondii. Manifestasi klinis pada toksoplasmosis okular kongenital adalah retinokoroiditis, paling banyak terletak di polus posterior. Diagnosis tokosoplasmosis okular kongenital ditegakkan dari hasil pemeriksaan klinis dengan pemeriksaan funduskopi dan serologi anak sekaligus dengan ibunya. Pada 75% bayi dengan infeksi congenital akan menunjukkan titer IgM antibodi anti-Toxoplasma yang positif. Penanganan yang lebih cepat akan mencegah pejalaran proses infeksi and kelainan perkembangan pada anak.
(JKS 2017; 2: 139-149)
Kata kunci : toksoplasmosis okular congenital, Toksoplasma gondii, retinokoroiditis
Abstract. Toxoplasmosis infection during pregnancy can cause congenital infection and manifest as blindness in the infant. Worldwide, about 0,5%-1% of pregnant women become contaminated by Toxoplasma gondii. Clinical manifestation of congenital ocular toxoplasmosis is retinochoroiditis, mostly at posterior pole.The diagnosis of congenital ocular toxoplasmosis is established clinically by funduscopy examination and serologic testing of neonate together with his/her mother. Anti-Toxoplasma antibodies of the IgM are found in 75% of infants with congenital toxoplasmosis. Early treatment may prevent the futher progress of the of the infectious process and the development disorders in children. (JKS 2017; 2: 139-149)
Keywords : congenital ocular toxoplasmosis, Toxoplasma gondii, retinochoroiditis,
Keywords
References
Daftar Pustaka
American Academy of Ophthalmology Staff. Pediatric Ophthalmology and Strabismus. Basic and Clinical Science Course. San Francisco: American Academy of Ophthalmology; 2005. p. 203-5.
Tabbara KF. Toxoplasmosis. In: Tasman W, editor. Clinical Ophthalmology. Hagerstown: Lippincott Williams & Wilkins; 2003. p. 1-43.
Pelloux H, Brennier-Pinchart M-P, Fricker-Hidalgo H. Protozoan Infections in Humans: Congenital Toxoplasmosis. European Journal of Protistology. 2003;39:444-8.
Holland GN. Ocular Toxoplasmosis: A Global Reassesment. Part I: Epidemyology and Course of Disease. American Journal of Ophthalmology. 2003;136:973-88.
Rorman E, Zamir CS, Rilkis I, Ben-David H. Congenital Toxoplasmosis-prenatal aspects of Toxoplasma gondii infection. Reproductive Toxicology. 2006;21:458-72.
Pataki M, Meszner Z, Todorova R. Congenital Toxoplasmosis. International Pediatrics. 2000;15:33-6.
Wright KW, Spiegel PH. Pediatric Ophthalmology and Strabismus. St. Louis: Mosby; 1999; 100-1.
Pinard JA, Leslie NS, Irvine PJ. Maternal Serologic Screening for Toxoplasmosis. Journal of Midwifery & Women's Health. 2003;48:308-16.
Gagne SS. Toxoplasmosis. Prim Care Update Ob/Gyns. 2001;8:122-6.
Bosch-Driessen LEH, Berendschot TTJM, Ongkosuwito JV, Rothova A. Ocular Tooxoplasmosis: Cinical Features and Prognosis of 154 Patients. Ophthalmology. 2002;109:869-78.
Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L, et al. Eye Manifestarions of Congenital Toxoplasmosis. American Journal of Ophthalmology. 1996;122(3):309-24.
Derouin F, Jacqz-Aigrain E, Thulliez P, Couvreur J, Leport C. Cotrimoxazole for Prenatal Treatment of Congenital Toxoplasmosis. Parasitology Today. 2000;16:254-6.
Wallon M, Liou C, Garner P, Peyron F. Congenital Toxoplasmosis: Systematic Review of Evidence of Eficacy of Treatment in Pregnancy. British Medical Journal. 1999;318:1511-4.
Cajal SRy. Retina. [cited May 8, 2006]; Available from: http://en.wikipedia.org/wiki/Retina Last Update: May 8, 2006
Newell FW. Ophthalmology Principles and Consepts. 5 ed. St. Louis: The C.V. Mosby Company; 1982; 12-29.
Kincaid MC, Green WR. Anatomy of The Vitreous, Retina, and Choroid. In: Regillo CD, Brown GC, Flynn HW, editors. Vitreoretinal Disease : The Essentials. New York: Thieme Medical Publisher; 1999. p. 11-22.
Regillo C, Chang TS, Johnson MW, Kaiser PK, Scott IU, Spaide R, et al. Retina and Vitreous. In: Staff AAO, editor. Basic and Clinical Science Course. San Francisco: American Academy of Ophthalmology; 2005. p. 148-50.
Schubert HD. Ocular Embryology. In: Regillo CD, Brown GC, Flynn HW, editors. Vitreoretinal Disease: The Essentials. New York: Thieme; 1999. p. 3-10.
Erickson M. [cited 2006 July 26]; Available from: http://www.stlukeseye.com/anatomy Last Update: 2004
S. L, Gandahusada S, Ismail S, Hendarto SK, Soetomenggolo T. Toksoplasmosis Kongenital. Majalah Kedokteran Indonesia. 1989;39:464-72.
Kahi S, J.N.Cozon G, Greenland T, Al M. Circulating Toxoplasma gondii-Specific Antibody-Secreting Cells in Patients with Congenital Toxoplasmosis. Clinical Immunology And Immunopathology. 1998;89:23-7.
Boyer KM. Congenital Toxoplasmosis: Current Status of Diagnosis, Treatment, and Prevention. Seminars in Pediatrics Infectious Diseases. 2000;11:165-71.
Jabs DA, Nguyen QD. Ocular Toxoplasmosis. In: Ryan SJ, editor. Retina. 3 ed. St. Louis: Mosby, Inc.; 2001. p. 1531-44.
Staff AAoO. Intraocular Inflammation and Uveitis. Basic and Clinical Science Course. San Francisco: American Academy of Ophthalmology; 2005. p. 164-9.
Wu L. Toxoplasmosis. 2005 [cited 2006 May 4]; Available from: http/ www.emedicine.com/oph/infectious_disease.htm Last Update: March 1, 2005
Breizin AP, Thulliez P, Couvreur J, Nobre R, Mcleod R, Mets MB. Ophthalmic Outcomes After Prenatal and Postnatal Treatment of Congenital Toxoplasmosis. American Journal of Ophthalmology. 2003;135:779-84.
Heath G. Basic Immunology. [cited 2006; Available from: www.optometry.co.uk Last Update: February 8, 2002
Janeway CA, Travers P, Walport M, Shlomchik MJ. Immunobiology: The Immune System in Health and Disease. [cited 2006 July 27]; Available from: www.garlandsscience.com Last Update: 2001
DOI: 10.24815/jks.v17i2.8993
Refbacks
- There are currently no refbacks.